-
Constraining Effect of Mild Portal Hypertension against the Negative Influence of Muscle Mass Loss in Cirrhosis after Esophageal Variceal Eradication
Kazufumi Kobayashi, Hitoshi Maruyama, Soichiro Kiyono, Sadahisa Ogasawara, Eiichiro Suzuki, Yoshihiko Ooka, Tetsuhiro Chiba, Naoya Kato, Tadashi Yamaguchi
Research Article: Clinical Investigation
-
Constraining Effect of Mild Portal Hypertension against the Negative Influence of Muscle Mass Loss in Cirrhosis after Esophageal Variceal Eradication
Kazufumi Kobayashi, Hitoshi Maruyama, Soichiro Kiyono, Sadahisa Ogasawara, Eiichiro Suzuki, Yoshihiko Ooka, Tetsuhiro Chiba, Naoya Kato, Tadashi Yamaguchi
Research Article: Clinical Investigation
-
Constraining Effect of Mild Portal Hypertension against the Negative Influence of Muscle Mass Loss in Cirrhosis after Esophageal Variceal Eradication
Kazufumi Kobayashi, Hitoshi Maruyama, Soichiro Kiyono, Sadahisa Ogasawara, Eiichiro Suzuki, Yoshihiko Ooka, Tetsuhiro Chiba, Naoya Kato, Tadashi Yamaguchi
Research Article: Clinical Investigation
-
Constraining Effect of Mild Portal Hypertension against the Negative Influence of Muscle Mass Loss in Cirrhosis after Esophageal Variceal Eradication
Kazufumi Kobayashi, Hitoshi Maruyama, Soichiro Kiyono, Sadahisa Ogasawara, Eiichiro Suzuki, Yoshihiko Ooka, Tetsuhiro Chiba, Naoya Kato, Tadashi Yamaguchi
Research Article: Clinical Investigation
-
Constraining Effect of Mild Portal Hypertension against the Negative Influence of Muscle Mass Loss in Cirrhosis after Esophageal Variceal Eradication
Kazufumi Kobayashi, Hitoshi Maruyama, Soichiro Kiyono, Sadahisa Ogasawara, Eiichiro Suzuki, Yoshihiko Ooka, Tetsuhiro Chiba, Naoya Kato, Tadashi Yamaguchi
Research Article: Clinical Investigation
-
Constraining Effect of Mild Portal Hypertension against the Negative Influence of Muscle Mass Loss in Cirrhosis after Esophageal Variceal Eradication
Kazufumi Kobayashi, Hitoshi Maruyama, Soichiro Kiyono, Sadahisa Ogasawara, Eiichiro Suzuki, Yoshihiko Ooka, Tetsuhiro Chiba, Naoya Kato, Tadashi Yamaguchi
Research Article: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation